MedTrace Logo

Proton Radiotherapy for Primary Central Nervous System Tumours in Adults

NCT02797366 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2016-06-13

No results posted yet for this study

Summary

Open label, multi-centre prospective study. Adult patients with primary central nervous system tumours fulfilling the inclusion criteria according to the study protocol. The study consists of 2 sequential cohorts evaluated consecutively for the feasibility, safety and toxicity, as well as long-term survival data, when using spot scanning proton beam therapy.

Conditions

  • Central Nervous System Tumour
  • Arteriovenous Malformation

Interventions

RADIATION

Proton radiotherapy

Sponsors & Collaborators

  • Sahlgrenska University Hospital

    collaborator OTHER

  • Karolinska University Hospital

    collaborator OTHER

  • University Hospital, Umeå

    collaborator OTHER

  • Region Örebro County

    collaborator OTHER

  • University Hospital, Linkoeping

    collaborator OTHER

  • Uppsala University

    lead OTHER

Principal Investigators

  • Petra Witt Nystrom, MD, PhD · Uppsala University Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2020-07-31
Completion
2030-07-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02797366 on ClinicalTrials.gov